Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors.Journal of neuro-oncology · 1995
   Trial
2. Targeting Subventricular Zone Progenitor Cells with Intraventricular Liposomal Encapsulated Cytarabine in Patients with Secondary Glioblastoma : A Report of Two Cases.SN comprehensive clinical medicine · 2020
   Article
3. Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma.Frontiers in oncology · 2020
   Article
4. External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma.Expert review of anticancer therapy · 2016
   Review
5. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.PloS one · 2012
   Article
6. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.International journal of nanomedicine · 2012
   Article
7. Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy.Journal of neuro-oncology · 2011
   Article
8. A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide.Cancer gene therapy · 2007
   Article
9. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.Journal of neuro-oncology · 2003
   Review
10. Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma.Brain pathology (Zurich, Switzerland) · 2003
    Article
11. Current and Future Gene Therapy for Malignant Gliomas.Journal of biomedicine & biotechnology · 2003
    Article
12. Telomerase as a therapeutic target for malignant gliomas.Oncogene · 2002
    Review
13. A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells.Oncogene · 2001
    Article
14. Liposome-mediated therapy of intracranial brain tumors in a rat model.Pharmaceutical research · 1997
    Article
15. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.The Journal of clinical investigation · 1994
    Article
16. Development of an in vitro extracellular matrix assay for studies of brain tumor cell invasion.Journal of neuro-oncology · 1994
    Article
17. Recurrent Glioblastoma: Where we stand.South Asian journal of cancer
    Review
18. Cellular plasticity regulated cancer stem cell niche: a possible new mechanism of chemoresistance.Cancer cell & microenvironment
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

10 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as